# Intensity Therapeutics, Inc.: Form S-1/A, filed Nov 2, 2022

- Company: [Intensity Therapeutics, Inc.](/companies/ints.md) (CIK 1567264)
- Form: S-1/A
- Filed: 2022-11-02
- Accepted by EDGAR: Nov 2, 2022, 09:40 ET
- Period: not reported
- Accession: 0001213900-22-068432
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1567264/000121390022068432/fs12022a10_intensity.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1567264/000121390022068432/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1567264/000121390022068432/fs12022a10_intensity.htm

Filed Nov 2, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-068432. Last ingested by Listed: Nov 5, 2026, 12:12 ET. No prices; not investment advice.
